Screener
Eton Pharmaceuticals, Inc. ETON Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | For the three months ended / March 31, 2026 | For the three months ended / March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | 1,875 | 1,161 |
| General and administrative | 10,446 | 9,170 |
| Total operating expenses | 12,321 | 10,331 |
| Income (loss) from operations | 2,414 | (470) |
| Other expense: | ||
| Interest and other expense, net | (840) | (1,028) |
| Income (loss) before income tax expense | 1,574 | (1,498) |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s other operating expenses?
- Eton Pharmaceuticals, Inc. (ETON) reported other operating expenses of $12.32M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
- Eton Pharmaceuticals, Inc.'s other operating expenses increased by 19.3% year-over-year, from $10.33M to $12.32M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s other operating expenses has grown at a 20.7% compound annual growth rate (CAGR), from $20.54M to $43.58M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about Eton Pharmaceuticals, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude